DiaMedica Therapeutics, Inc. (DMAC)
6.39
-0.36
(-5.33%)
USD |
NASDAQ |
Aug 28, 16:00
6.39
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Total Liabilities (Quarterly) : 6.663M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.663M |
| March 31, 2026 | 5.845M |
| December 31, 2025 | 5.26M |
| September 30, 2025 | 5.425M |
| June 30, 2025 | 4.30M |
| March 31, 2025 | 4.876M |
| December 31, 2024 | 5.627M |
| September 30, 2024 | 4.56M |
| June 30, 2024 | 3.376M |
| March 31, 2024 | 2.911M |
| December 31, 2023 | 3.103M |
| September 30, 2023 | 2.51M |
| June 30, 2023 | 2.307M |
| March 31, 2023 | 3.195M |
| December 31, 2022 | 2.568M |
| September 30, 2022 | 1.962M |
| June 30, 2022 | 1.543M |
| March 31, 2022 | 1.443M |
| December 31, 2021 | 1.527M |
| September 30, 2021 | 1.628M |
| June 30, 2021 | 1.456M |
| March 31, 2021 | 1.211M |
| December 31, 2020 | 2.081M |
| September 30, 2020 | 1.512M |
| June 30, 2020 | 1.309M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.042M |
| December 31, 2019 | 1.436M |
| September 30, 2019 | 1.339M |
| June 30, 2019 | 1.095M |
| March 31, 2019 | 1.588M |
| December 31, 2018 | |
| September 30, 2018 | 4.079M |
| June 30, 2018 | 4.921M |
| March 31, 2018 | 3.167M |
| December 31, 2017 | 1.026M |
| September 30, 2017 | 1.055M |
| June 30, 2017 | 1.225M |
| March 31, 2017 | 1.064M |
| December 31, 2016 | |
| September 30, 2016 | 1.496M |
| June 30, 2016 | 1.466M |
| March 31, 2016 | 1.403M |
| December 31, 2015 | 1.450M |
| September 30, 2015 | 1.347M |
| June 30, 2015 | 1.462M |
| March 31, 2015 | 1.695M |
| December 31, 2014 | 1.815M |
| September 30, 2014 | 1.406M |
| June 30, 2014 | 1.639M |
| March 31, 2014 | 2.283M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.00M |
| Shareholders Equity (Quarterly) | 38.34M |
| Debt to Equity Ratio | 0.0048 |
| Current Ratio | 6.720 |
| Net Debt Paydown Yield | 0.01% |